Found: 13
Select item for more details and to access through your institution.
Glial cell line-derived neurotrophic factor (GDNF) is an endogenous protector in the mesolimbic system against excessive alcohol consumption and relapse.
- Published in:
- Addiction Biology, 2015, v. 20, n. 4, p. 629, doi. 10.1111/adb.12152
- By:
- Publication type:
- Article
MRI-guided targeting of entorhinal cortex for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2014, v. 10, p. P862, doi. 10.1016/j.jalz.2014.05.1720
- By:
- Publication type:
- Article
Automated Segmentation Tool for Brain Infusions.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0064452
- By:
- Publication type:
- Article
Regeneration of the MPTP-Lesioned Dopaminergic System after Convection-Enhanced Delivery of AAV2-GDNF.
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 28, p. 9567, doi. 10.1523/JNEUROSCI.0942-10.2010
- By:
- Publication type:
- Article
AAV9-mediated Expression of a Non-self Protein in Nonhuman Primate Central Nervous System Triggers Widespread Neuroinflammation Driven by Antigen-presenting Cell Transduction.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 2, p. 329, doi. 10.1038/mt.2013.266
- By:
- Publication type:
- Article
Magnetic resonance imaging-guided phase 1 trial of putaminal AADC gene therapy for Parkinson's disease.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 6, p. 1048, doi. 10.1038/mt.2011.11
- By:
- Publication type:
- Article
Anterograde Axonal Transport of AAV2-GDNF in Rat Basal Ganglia.
- Published in:
- Molecular Therapy, 2011, v. 19, n. 5, p. 922, doi. 10.1038/mt.2010.248
- By:
- Publication type:
- Article
Real-time MR Imaging With Gadoteridol Predicts Distribution of Transgenes After Convection-enhanced Delivery of AAV2 Vectors.
- Published in:
- Molecular Therapy, 2010, v. 18, n. 8, p. 1490, doi. 10.1038/mt.2010.114
- By:
- Publication type:
- Article
250. Protection Against Huntington's Diease Progression: AAV-Mediated Delivery of Biotherapeutics.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S95, doi. 10.1016/j.ymthe.2006.08.277
- By:
- Publication type:
- Article
AAV-Mediated gene delivery of BDNF or GDNF is neuroprotective in a model of huntington disease
- Published in:
- Molecular Therapy, 2004, v. 9, n. 5, p. 682, doi. 10.1016/j.ymthe.2004.02.016
- By:
- Publication type:
- Article
Novel Platform for MRI-Guided Convection-Enhanced Delivery of Therapeutics: Preclinical Validation in Nonhuman Primate Brain.
- Published in:
- Stereotactic & Functional Neurosurgery, 2011, v. 89, n. 3, p. 141, doi. 10.1159/000323544
- By:
- Publication type:
- Article
An Engineered Zinc Finger Protein Activator of the Endogenous Glial Cell Line-Derived Neurotrophic Factor Gene Provides Functional Neuroprotection in a Rat Model of Parkinson's Disease.
- Published in:
- Journal of Neuroscience, 2010, v. 30, n. 48, p. 16469, doi. 10.1523/JNEUROSCI.2440-10.2010
- By:
- Publication type:
- Article